Aspirin / butalbital / caffeine Alternatives Compared
| Aspirin / butalbital / caffeine | Ubrelvy (ubrogepant) | Nurtec ODT (rimegepant) |
|
|---|
| Aspirin / butalbital / caffeine | Ubrelvy (ubrogepant) | Nurtec ODT (rimegepant) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Migraine, Pain, Headache. Aspirin / butalbital / caffeine may also be used for purposes not listed in this medication guide. |
Prescription only
Ubrelvy is a prescription medicine that may be used to treat acute migraine attacks in adults and works by blocking the effects of a protein, called CGRP that is thought to play a role in migraine... View more |
Prescription only
Nurtec ODT may be placed onto or under the tongue to treat the symptoms of migraine in adults, and it may also be used to prevent episodic migraine when taken every second day. Nurtec ODT works by... View more |
Related suggestions Migraine
|
|||||||||||||||||||||||
| More about Aspirin / butalbital / caffeine | More about Ubrelvy (ubrogepant) | More about Nurtec ODT (rimegepant) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Aspirin / butalbital / caffeine has an average rating of 8.9 out of 10 from a total of 128 ratings on Drugs.com. 88% of reviewers reported a positive effect, while 5% reported a negative effect. |
Ubrelvy has an average rating of 6.5 out of 10 from a total of 278 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 33% reported a negative effect. |
Nurtec ODT has an average rating of 6.5 out of 10 from a total of 337 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Ubrelvy side effects |
View all Nurtec ODT side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
|
View all Ubrelvy prices |
View all Nurtec ODT prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Farbital, Fiorinal, Fiormor, Fiortal, Fortabs |
N/A |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
35 hours |
7 hours |
11 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 896 drugs are known to interact with Aspirin / butalbital / caffeine:
|
A total of 248 drugs are known to interact with Ubrelvy:
|
A total of 171 drugs are known to interact with Nurtec ODT:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
May 04, 1976 |
December 23, 2019 |
February 27, 2020 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.